New Study Finds DXA Osteoporosis Screening Declined 35% Among Medicare Beneficiaries
A new HPI study reveals a substantial decline in DXA testing among Medicare beneficiaries that was greatest in certain underserved groups. The findings raise concerns about missed opportunities to diagnose osteoporosis and prevent fractures and associated costs. The study analyzed nearly two decades of Medicare claims data from more than 5 million beneficiaries and found that use of DXA fell by 35% over the study period. Read More